Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Mar 11;320(7236):677-9.
doi: 10.1136/bmj.320.7236.677.

Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?

S Ramachandran  1 , J M French, M P Vanderpump, P Croft, R H Neary
Affiliations

Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?

S Ramachandran et al. BMJ. .

Erratum in

  • BMJ. 2001 Jan 20;322(7279):150
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Coronary risk factors in patients being considered for lipid lowering drugs. Values are means (SD)
See this image and copyright information in PMC

Comment in

References

    1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–1307. - PubMed
    1. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol lower risk of ischaemic heart disease? BMJ. 1994;308:367–372. - PMC - PubMed
    1. West of Scotland Coronary Prevention Group. West of Scotland coronary prevention study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996;348:1339–1342. - PubMed
    1. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease. Br Med Bull. 1994;50:272–298. - PubMed
    1. Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet. 1998;351:233–241. - PubMed

Publication types

Substances